News | News By Subject | News by Disease News By Date | Search News

Gastric cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN)'s Gastric Cancer Drug Lynparza Flunks Phase III Test     5/18/2016
Sneak Peak of Five Prime (FPRX)'s Prelim Phase I Tumor Data Leaves Investors Happy     1/22/2016
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation     12/28/2015
SoCal's Halozyme (HALO) To Expand With A Satellite Office In San Francisco     11/18/2015
ImmunoGen (IMGN), Roche (RHHBY)'s Kadcyla Flunks Late-Stage Study     10/23/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Amgen (AMGN) Terminates All Rilotumumab Clinical Trials For Advanced Gastric Cancer     11/26/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Eli Lilly (LLY) Wins FDA Approval For Gastric Cancer Combination Drug     11/6/2014
Merck & Co. (MRK)'s Keytruda Shows Positive Signs In Bladder Cancer Trial     9/30/2014
Merck & Co. (MRK)'s Keytruda Extends Immune System Fight To Stomach Cancer     9/29/2014
FDA Approves Eli Lilly and Company (LLY)'s Cyramza For Stomach Cancer     4/23/2014
Eli Lilly and Company (LLY) Experimental Cancer Drug Ramucirumab Misses a Lucrative Target     9/27/2013
UK's National Institute for Clinical Excellence (NICE) Rejects Sanofi (France) (SAN.PA) Bowel Cancer Drug     6/21/2013

News from Around the Web
Sugar Helping Map New Ground Against Deadly Bug, University of Guelph Study     4/19/2011
Mixed Results for Liposomal Irinotecan, Royal Marsden Hospital Study     1/24/2011
Drug Active in Resistant Gastrointestinal Stromal Tumors, American Society of Clinical Oncology Reveals     1/20/2011
School Milk Prevents Bowel Cancer, University of Otago Study Finds     1/19/2011
Gene May Be a Target of Stomach Cancer Treatment, University of Tokyo Study     12/29/2010
Red Meat Linked to Esophageal, Stomach Cancer Risks, National Cancer Institute Study     11/8/2010
Genta Incorporated (GETA.OB) Tesetaxel Granted Orphan Drug Designation for Gastric Cancer by European Medicines Evaluation Agency     10/11/2010
Drug Appears to Prolong Survival in Stomach Cancer Patients, Seoul National University and University Hospital Gasthuisberg Study     8/20/2010
Telomere Length May Predict Cancer Risk, Innsbruck Medical University Study     7/7/2010
Gene Regulation: Can We Stomach It? New Technique Fights Against Cause of Peptic Ulcer Disease and Gastric Cancer, Max Planck Institute Study     3/4/2010
Combination Of Two Targeted Therapies Effective Against Subset Of Gastric Cancers, University of California, Los Angeles (UCLA) Study     3/3/2010
Cancer: New Explanation Of 'Asian Paradox'     10/29/2009
Acrylamide Doesn't Raise Gastrointestinal Cancer Risk, Maastricht University Study     10/21/2008
Getting Rid of Bacteria Cuts Stomach Cancer Risk, Hokkaido University Scientists Find     8/1/2008
Ulcer Bacteria May Protect From Asthma: New York University Study     7/15/2008

Press Releases
Arog Pharmaceuticals Receives FDA Fast Track Designation For Crenolanib For Advanced Gastrointestinal Stromal Tumors With A D842V Mutation In The PDGFRA Gene     11/17/2016
Investors Ecstatic as Bristol-Myers Squibb (BMY)'s Opdivo Delivers in Late-Stage Stomach Cancer Study     11/10/2016
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Proposed Biosimilar Trastuzumab Accepted For Review By EMA     8/25/2016
AbGenomics Corporation Announces FDA Acceptance To Commence Phase I Clinical Trial Of Abgn-107 ADC Candidate For Pancreatic, Gastric, And Colorectal Cancer Treatments     8/15/2016
LSK BioPharma Announces Successful Outcome From End-Of-Phase 2 Meeting With FDA     7/26/2016
Halozyme (HALO) Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA     7/25/2016
Boston Biomedical Announces First Orphan Drug Designation For Napabucasin In Gastric/GEJ Cancer     6/23/2016
ASCO2016: GANYMED Pharmaceuticals AG's IMAB362 Extends Survival In Gastric Cancer     6/6/2016
Halozyme (HALO) Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment     4/19/2016
XBiotech USA (XBIT) To Present Pivotal Phase III Data On Xilonix At European Society Of Medical Oncology’s World Congress On Gastrointestinal Cancer     4/19/2016
Boston Biomedical's Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured At The ASCO 2016 Gastrointestinal Cancers Symposium     1/25/2016
Merck & Co. (MRK) Release: Data For KEYTRUDA (pembrolizumab) In A Range Of Gastrointestinal Cancers To Be Presented At 2016 Gastrointestinal Cancers Symposium     1/19/2016
Merck & Co. (MRK) Release: Data For KEYTRUDA (Pembrolizumab) In A Range Of Gastrointestinal Cancers To Be Presented At 2016 Gastrointestinal Cancers Symposium     1/19/2016
Halozyme (HALO) Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing     1/4/2016
Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) Initiate Two Phase III Studies Of Investigational Immunotherapy Avelumab In Advanced Gastric And Gastro-Esophageal Junction Cancers     12/9/2015

//-->